EXACT SCIENCES CORP·4

Mar 23, 9:17 AM ET

Trigg Leslie 4

Research Summary

AI-generated summary

Updated

Exact Sciences (EXAS) Director Trigg Leslie Sells 17,169 Shares in Merger

What Happened
Trigg Leslie, a director of Exact Sciences Corporation (EXAS), recorded two dispositions to the issuer on March 23, 2026: 3,244 shares and 13,925 shares, which were converted into merger consideration in connection with Abbott’s acquisition of Exact Sciences. Under the Merger Agreement each share outstanding (with certain exceptions) was converted into the right to receive $105.00 in cash, so the 17,169 shares equate to roughly $1,802,745 in gross consideration (subject to applicable tax withholding).

Key Details

  • Transaction date: March 23, 2026 (Effective Time of the merger).
  • Consideration: $105.00 per share under the Merger Agreement (Disposition code D — shares surrendered to the issuer).
  • Shares disposed: 3,244 + 13,925 = 17,169 total.
  • Approximate gross value: 17,169 × $105 = $1,802,745 (taxes/withholding may reduce net proceeds).
  • Shares owned after the transaction: not specified in the filing.
  • Footnotes: F1 confirms the Merger with Abbott and the $105 cash consideration; F2 states restricted/vesting shares were deemed fully vested and converted and are subject to withholding.
  • Filing timeliness: Reported on the same date (March 23, 2026), so appears timely.

Context
This was not an open-market sale but a cash-out disposition required by the merger—shares were cancelled and converted into the negotiated merger cash consideration. That means the transaction reflects deal mechanics (merger consideration and any tax withholding), not a director-initiated market trade that might signal personal views on the stock.